Stock ETNB 89BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart 89bio, Inc.

Equities

ETNB

US2825591033

Market Closed - Nasdaq
Other stock markets
 20:59:52 29/05/2024 BST 		5-day change 1st Jan Change
8.03 USD -3.49% Intraday chart for 89bio, Inc. -10.08% -28.11%
05-14 89Bio Initiates Phase 3 Enlighten-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis Patients with Compensated Cirrhosis CI
05-10 HC Wainwright Adjusts 89bio's Price Target to $29 From $31, Maintains Buy Rating MT
9.ILYo6WpPjKNdzJrSErfB6xqEgoLJSfj-pF7stBR2LuM.UuZemQt47dc-9M20I86phGLg5eOTMc_MlS6P3nsCaqZ55H3QLST6yjq5-Q~01e3ddf6b0949eea77bcf8c4b792f21d
  1. Stock Market
  2. Equities
  3. ETNB Stock
  4. Charts 89bio, Inc.
  5. News Chart